{"id":"W4361295263","doi":"10.1186/s13046-023-02649-6","title":"First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors","year":2023,"lang":"en","type":"article","venue":"Journal of Experimental & Clinical Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Precision BioLogic (Canada)","funders":"National Cancer Institute","keywords":"Medicine; Neutropenia; Internal medicine; Febrile neutropenia; Pharmacokinetics; Gastroenterology; Clinical trial; Refractory (planetary science); Oncology; Toxicity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006401884,0.0002216043,0.0008360305,0.000534884,0.0001329413,0.00003909961,0.0005608021,0.0003297011,0.0003184778],"category_scores_gemma":[0.0013339,0.0001861435,0.0005251931,0.0006458401,0.000538134,0.00002907653,0.0002815056,0.001043665,0.00001531959],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002106869,"about_ca_system_score_gemma":0.0009915554,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004825126,"about_ca_topic_score_gemma":0.0002230767,"domain_scores_codex":[0.9943106,0.0009422158,0.002493209,0.0005251808,0.001016887,0.0007118749],"domain_scores_gemma":[0.997891,0.0004578502,0.0005300581,0.0003660765,0.000376761,0.0003782435],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.04270177,0.008019448,0.08653694,0.00003546189,0.0001703247,0.0004814168,0.0002333592,0.0002342027,0.8546176,0.00001829532,0.002520865,0.004430297],"study_design_scores_gemma":[0.2578196,0.07275956,0.05505645,0.0006164214,0.00003056431,0.00003950215,0.003051894,0.001761635,0.5738115,0.0001237974,0.03418267,0.0007464098],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969165,0.00134966,0.000004869995,0.0003144021,0.0004663149,0.0007086273,0.00003469285,0.000005482008,0.0001994905],"genre_scores_gemma":[0.9946073,0.003390661,0.00009003269,0.00003338728,0.001394196,0.00006299467,0.00006666222,0.00003931707,0.000315414],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2808061,"threshold_uncertainty_score":0.7590711,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2503249849082375,"score_gpt":0.5989433629434179,"score_spread":0.3486183780351804,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}